[go: up one dir, main page]

NO169996C - Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff - Google Patents

Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff

Info

Publication number
NO169996C
NO169996C NO853407A NO853407A NO169996C NO 169996 C NO169996 C NO 169996C NO 853407 A NO853407 A NO 853407A NO 853407 A NO853407 A NO 853407A NO 169996 C NO169996 C NO 169996C
Authority
NO
Norway
Prior art keywords
separation
drug
preparing
procedure
pharmaceutical preparation
Prior art date
Application number
NO853407A
Other languages
English (en)
Norwegian (no)
Other versions
NO853407L (no
NO169996B (no
Inventor
Bo Magnus Ekman
Aake Rikard Lindahl
Original Assignee
Gacell Lab Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gacell Lab Ab filed Critical Gacell Lab Ab
Publication of NO853407L publication Critical patent/NO853407L/no
Publication of NO169996B publication Critical patent/NO169996B/no
Publication of NO169996C publication Critical patent/NO169996C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO853407A 1984-09-06 1985-08-29 Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff NO169996C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (3)

Publication Number Publication Date
NO853407L NO853407L (no) 1986-03-07
NO169996B NO169996B (no) 1992-05-25
NO169996C true NO169996C (no) 1992-09-02

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853407A NO169996C (no) 1984-09-06 1985-08-29 Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff

Country Status (21)

Country Link
US (1) US4824678A (xx)
EP (1) EP0173928B1 (xx)
JP (1) JP2527713B2 (xx)
KR (1) KR930003114B1 (xx)
AT (1) ATE53490T1 (xx)
AU (1) AU576891B2 (xx)
CA (1) CA1252723A (xx)
DE (1) DE3578123D1 (xx)
DK (1) DK164256C (xx)
ES (1) ES8702138A1 (xx)
FI (1) FI87042C (xx)
GR (1) GR852158B (xx)
HU (1) HU194495B (xx)
IE (1) IE58263B1 (xx)
IL (2) IL76256A (xx)
NO (1) NO169996C (xx)
NZ (1) NZ213245A (xx)
PH (1) PH22119A (xx)
PT (1) PT81092B (xx)
SE (1) SE8404467D0 (xx)
ZA (1) ZA856547B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
WO1992002212A2 (en) * 1990-08-07 1992-02-20 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
JPH08507806A (ja) * 1993-03-09 1996-08-20 ミドルセツクス・サイエンシーズ・インコーポレーテツド 高分子の微粒子および調製法
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
MXPA03012041A (es) * 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
BR0206441A (pt) * 2001-12-19 2003-12-30 Astrazeneca Ab Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
EP3331502B1 (en) 2015-08-07 2021-05-26 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP3796908B1 (en) 2018-11-16 2023-05-10 Santa Farma Ilaç Sanayi A.S. Controlled release propiverine formulations
EP4251154A4 (en) 2020-11-27 2024-07-31 Santa Farma Ilac Sanayii A.S. SUSTAINED-RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (xx) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
EP0173928A1 (en) 1986-03-12
PT81092A (en) 1985-10-01
FI87042B (fi) 1992-08-14
NZ213245A (en) 1988-06-30
KR860002271A (ko) 1986-04-24
JP2527713B2 (ja) 1996-08-28
HUT40333A (en) 1986-12-28
NO853407L (no) 1986-03-07
DE3578123D1 (de) 1990-07-19
DK400685D0 (da) 1985-09-02
FI87042C (fi) 1992-11-25
PH22119A (en) 1988-06-01
HU194495B (en) 1988-02-29
NO169996B (no) 1992-05-25
IE852070L (en) 1986-03-06
AU4693585A (en) 1986-03-13
FI853406A0 (fi) 1985-09-05
ZA856547B (en) 1986-04-30
EP0173928B1 (en) 1990-06-13
ES8702138A1 (es) 1986-12-16
IL76256A0 (en) 1986-01-31
IE58263B1 (en) 1993-08-25
AU576891B2 (en) 1988-09-08
KR930003114B1 (ko) 1993-04-19
JPS61112013A (ja) 1986-05-30
ATE53490T1 (de) 1990-06-15
GR852158B (xx) 1986-01-08
DK400685A (da) 1986-03-07
CA1252723A (en) 1989-04-18
DK164256B (da) 1992-06-01
FI853406L (fi) 1986-03-07
ES546728A0 (es) 1986-12-16
PT81092B (pt) 1988-01-22
DK164256C (da) 1992-10-19
SE8404467D0 (sv) 1984-09-06
IL76257A (en) 1989-05-15
IL76256A (en) 1990-06-10
US4824678A (en) 1989-04-25

Similar Documents

Publication Publication Date Title
NO169996C (no) Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
CA2033277A1 (en) Controlled release pharmaceutical preparation and method for producing the same
IE883810L (en) Sustained release pharmaceutical compositions
CA2281420A1 (en) Preparation of pharmaceutically-active granules
KR880004804A (ko) 분무건조 아세트 아미노펜
NO863997L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
ATE79026T1 (de) Feste pharmazeutische retardform.
ATE133333T1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoffreigabe und verfahren zur herstellung derselben
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
EP0171528A3 (en) Controlled release pharmaceutical preparations
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
JP4160122B2 (ja) 複数の連続する制御された放出を持った多粒子製薬形態の調製方法
ATE72974T1 (de) Diltiazem-mikrokugeln, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen mit gesteuerter abgabe.
FI900017A0 (fi) Menetelmä tehoainetta alhaisen annoksen kontrolloidusti vapauttavien aspiriinitablettien valmistamiseksi
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
AUPM814994A0 (en) Codeine-containing formulations

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002